company background image
BAYN

Bayer XTRA:BAYN Stock Report

Last Price

€53.42

Market Cap

€53.4b

7D

-1.2%

1Y

-19.8%

Updated

30 May, 2023

Data

Company Financials +

BAYN Stock Overview

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide.

BAYN fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance3/6
Financial Health2/6
Dividends3/6

My Notes

Capture your thoughts, links and company narrative

Bayer Aktiengesellschaft Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Bayer
Historical stock prices
Current Share Price€53.42
52 Week High€67.49
52 Week Low€46.70
Beta1.15
1 Month Change-10.61%
3 Month Change-5.18%
1 Year Change-19.77%
3 Year Change-16.45%
5 Year Change-47.16%
Change since IPO292.23%

Recent News & Updates

Recent updates

Bayer (ETR:BAYN) Use Of Debt Could Be Considered Risky

Dec 07
Bayer (ETR:BAYN) Use Of Debt Could Be Considered Risky

Is Bayer (ETR:BAYN) A Risky Investment?

Aug 18
Is Bayer (ETR:BAYN) A Risky Investment?

Results: Bayer Aktiengesellschaft Exceeded Expectations And The Consensus Has Updated Its Estimates

May 13
Results: Bayer Aktiengesellschaft Exceeded Expectations And The Consensus Has Updated Its Estimates

Bayer (ETR:BAYN) Has A Somewhat Strained Balance Sheet

Mar 02
Bayer (ETR:BAYN) Has A Somewhat Strained Balance Sheet

These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt Extensively

Oct 31
These 4 Measures Indicate That Bayer (ETR:BAYN) Is Using Debt Extensively

Bayer (ETR:BAYN) Has A Somewhat Strained Balance Sheet

Jul 18
Bayer (ETR:BAYN) Has A Somewhat Strained Balance Sheet

Should You Buy Bayer Aktiengesellschaft (ETR:BAYN) For Its 3.7% Dividend?

May 03
Should You Buy Bayer Aktiengesellschaft (ETR:BAYN) For Its 3.7% Dividend?

Does Bayer (ETR:BAYN) Have A Healthy Balance Sheet?

Mar 11
Does Bayer (ETR:BAYN) Have A Healthy Balance Sheet?

Bayer's(ETR:BAYN) Share Price Is Down 45% Over The Past Three Years.

Feb 13
Bayer's(ETR:BAYN) Share Price Is Down 45% Over The Past Three Years.

How Does Bayer Aktiengesellschaft (ETR:BAYN) Fare As A Dividend Stock?

Jan 17
How Does Bayer Aktiengesellschaft (ETR:BAYN) Fare As A Dividend Stock?

What Kind Of Investors Own Most Of Bayer Aktiengesellschaft (ETR:BAYN)?

Dec 13
What Kind Of Investors Own Most Of Bayer Aktiengesellschaft (ETR:BAYN)?

Is Bayer (ETR:BAYN) A Risky Investment?

Nov 22
Is Bayer (ETR:BAYN) A Risky Investment?

Shareholder Returns

BAYNDE PharmaceuticalsDE Market
7D-1.2%-0.01%-1.3%
1Y-19.8%-12.7%-8.5%

Return vs Industry: BAYN underperformed the German Pharmaceuticals industry which returned -12.7% over the past year.

Return vs Market: BAYN underperformed the German Market which returned -8.5% over the past year.

Price Volatility

Is BAYN's price volatile compared to industry and market?
BAYN volatility
BAYN Average Weekly Movement3.4%
Pharmaceuticals Industry Average Movement5.2%
Market Average Movement5.0%
10% most volatile stocks in DE Market9.9%
10% least volatile stocks in DE Market2.7%

Stable Share Price: BAYN is less volatile than 75% of German stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: BAYN's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1863101,735Werner Baumannhttps://www.bayer.com

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy.

Bayer Aktiengesellschaft Fundamentals Summary

How do Bayer's earnings and revenue compare to its market cap?
BAYN fundamental statistics
Market Cap€53.39b
Earnings (TTM)€3.04b
Revenue (TTM)€50.49b

17.3x

P/E Ratio

1.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BAYN income statement (TTM)
Revenue€50.49b
Cost of Revenue€19.44b
Gross Profit€31.05b
Other Expenses€28.01b
Earnings€3.04b

Last Reported Earnings

Mar 31, 2023

Next Earnings Date

Aug 08, 2023

Earnings per share (EPS)3.09
Gross Margin61.49%
Net Profit Margin6.02%
Debt/Equity Ratio105.6%

How did BAYN perform over the long term?

See historical performance and comparison

Dividends

4.5%

Current Dividend Yield

78%

Payout Ratio